Skip to main content
. 2020 Aug 20;19:1533033820948054. doi: 10.1177/1533033820948054

Figure 4.

Figure 4.

HMGB1 activates the Wnt/β-catenin pathway in lung cancer A549 and H1299 cells. (A) Western blotting was used to analyze the major biomarkers of EMT in HMGB1-knockdown A549 cells and HMGB1-overexpressing H1299 cells. (B) Western blot analysis was performed to detect factors involved in Wnt/β-catenin signaling in HMGB1-depleted A549 cells and HMGB1-overexpressing H1299 cells. (C) qRT-PCR was performed to detect factors involved in Wnt/β-catenin signaling in HMGB1-depleted A549 cells and HMGB1-overexpressing H1299 cells.